151 related articles for article (PubMed ID: 2345708)
1. Perspectives on the improvement of quality of life with epoetin alfa therapy.
Lundin AP; Delano BG; Quinn-Cefaro R
Pharmacotherapy; 1990; 10(2 ( Pt 2)):22S-26S. PubMed ID: 2345708
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life.
Nissenson AR
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):25-31. PubMed ID: 2669083
[TBL] [Abstract][Full Text] [Related]
3. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
Lundin AP
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and hematocrit level.
Levin NW
Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):16-20. PubMed ID: 1626552
[TBL] [Abstract][Full Text] [Related]
5. Review of patients' responses to epoetin alfa therapy.
Krantz SB
Pharmacotherapy; 1990; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
[TBL] [Abstract][Full Text] [Related]
6. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients.
Delano BG
Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):14-8. PubMed ID: 2757025
[TBL] [Abstract][Full Text] [Related]
7. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
8. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
Binkley LS
Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
[No Abstract] [Full Text] [Related]
9. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis.
Evans RW
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):62-70. PubMed ID: 1928082
[TBL] [Abstract][Full Text] [Related]
10. rHuEPO and treatment outcomes: the clinical experience.
Hudis CA; Van Belle S; Chang J; Muenstedt K
Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
[TBL] [Abstract][Full Text] [Related]
11. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin.
Bárány P; Pettersson E; Konarski-Svensson JK
Nephrol Dial Transplant; 1993; 8(5):426-32. PubMed ID: 8393547
[TBL] [Abstract][Full Text] [Related]
13. The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem.
Glaspy J
Semin Hematol; 1997 Jul; 34(3 Suppl 2):20-6. PubMed ID: 9253780
[TBL] [Abstract][Full Text] [Related]
14. The quality of life of dialysis patients treated with recombinant human erythropoietin.
Auer J; Oliver DO; Winearls CG
Scand J Urol Nephrol Suppl; 1990; 131():61-5. PubMed ID: 2075472
[TBL] [Abstract][Full Text] [Related]
15. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
16. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and anemia: the nephrology experience.
Macdougall IC
Semin Oncol; 1998 Jun; 25(3 Suppl 7):39-42. PubMed ID: 9671329
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.
Mystakidou K; Kalaidopoulou O; Katsouda E; Parpa E; Kouskouni E; Chondros C; Tsiatas ML; Vlahos L
Anticancer Res; 2005; 25(5):3495-500. PubMed ID: 16101168
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
Mohini R
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
[TBL] [Abstract][Full Text] [Related]
20. In search of an optimal hematocrit level in dialysis patients: rehabilitation and quality-of-life implications.
Paganini EP
Am J Kidney Dis; 1994 Jul; 24(1 Suppl 1):S10-6; discussion S31-2. PubMed ID: 8023833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
